Donoghue Forlines LLC Eli Lilly & CO Transaction History

Donoghue Forlines LLC

$342 Million
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $73,001 - $86,059	-139 Reduced 5.81%	2,254 $1.31 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $182,574 - $251,705	-420 Reduced 14.93%	2,393 $1.29 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $877,902 - $1.17 Million	-2,503 Reduced 47.08%	2,813 $1.32 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $27,646 - $32,468	89 Added 1.7%	5,316 $1.83 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $254,346 - $296,363	791 Added 17.83%	5,227 $1.91 Million
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $1.38 Million - $1.57 Million	-4,638 Reduced 51.11%	4,436 $1.43 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $797,725 - $936,646	-2,862 Reduced 23.98%	9,074 $2.94 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $85,896 - $106,747	366 Added 3.16%	11,936 $3.42 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $18,887 - $23,439	-84 Reduced 0.72%	11,570 $3.2 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.58 Million - $3.18 Million	11,654 New	11,654 $2.69 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $1.54 Million - $1.99 Million	-8,523 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $265,541 - $343,755	1,616 Added 23.4%	8,523 $1.59 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $901,087 - $1.19 Million	6,907 New	6,907 $1.17 Million
Q4 2018 Jan 24, 2019	SELL	$105.9 - $118.64 $16.2 Million - $18.2 Million	-153,186 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$85.86 - $107.31 $5.09 Million - $6.36 Million	-59,306 Reduced 27.91%	153,186 $16.4 Million
Q2 2018 Jul 26, 2018	SELL	$75.7 - $86.88 $916,954 - $1.05 Million	-12,113 Reduced 5.39%	212,492 $18.1 Million
Q1 2018 May 03, 2018	BUY	$74.21 - $87.6 $16.7 Million - $19.7 Million	224,605 New	224,605 $17.4 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $16 Million - $17.1 Million	-194,866 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $171,172 - $189,984	-2,221 Reduced 1.13%	194,866 $16.7 Million
Q2 2017 Sep 12, 2017	BUY	N/A	197,087	197,087 $16.2 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$88.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.9M
Shares

$67.2 Billion
1.31% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$59.9 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$46.7 Billion
31.1% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$30.8 Billion
1.36% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Donoghue Forlines LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donoghue Forlines LLC with notifications on news.

Account